Lovenox Injection
Product Images NDC 0075-8030

Product Visual Gallery

This gallery contains 32 technical images submitted to the FDA as part of the official labeling for Lovenox (NDC 0075-8030). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sanofi-aventis U.s. Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Lovenox Premier 01

An instructional illustration showing a syringe and a vial. A hand is holding the vial in one hand and a syringe in the other, with an arrow indicating the action of drawing fluid from the vial into the syringe. The background is yellow. This relates to the preparation of an injection.*

FDA Label Image

Lovenox Premier 02

An instructional illustration depicting the administration of Lovenox (enoxaparin sodium) injection subcutaneously. The image shows a hand injecting the medication into the fatty layer just under the skin, with an arrow indicating the direction of injection insertion.*

FDA Label Image

Lovenox Premier 03

An instructional illustration showing how to remove the protective needle cap from a Lovenox prefilled syringe for subcutaneous injection. A hand is holding the syringe and pulling the cap off in the indicated direction.*

FDA Label Image

Lovenox Premier 04

An instructional illustration showing a hand holding a syringe, with a blue arrow indicating the rotation or turning direction of the syringe plunger, likely demonstrating how to prepare or administer the injection.*

FDA Label Image

Lovenox Premier 05

An instructional illustration showing a hand disposing of a syringe into a designated container labeled 'BIOHAZARD' for safe medical waste disposal. The image emphasizes proper disposal of injection materials.*

FDA Label Image

Lovenox Premier 06

Chemical structure diagram depicting the molecular arrangement of enoxaparin sodium, the active ingredient in Lovenox. The structure includes repeating units with labeled substituents and functional groups, illustrating its polysaccharide composition.*

FDA Label Image

Lovenox Premier 07

Chemical structure diagram of enoxaparin sodium, the active ingredient in Lovenox injection. The diagram shows molecular components and bonds typical to the enoxaparin sodium compound.*

FDA Label Image

Lovenox Premier 08

A horizontal forest plot showing relative risk comparison for multiple patient subgroups between unfractionated heparin (UFH) and enoxaparin (Enox). Each subgroup lists number of patients and plots a point estimate with confidence intervals on a scale where values below 1 favor enoxaparin. Columns include percentage values for UFH and enoxaparin and the calculated reduction in risk.*

FDA Label Image

Lovenox Premier 09

A survival analysis graph displaying the hazard distribution function over time (days) to death or myocardial re-infarction, comparing enoxaparin and UFH (unfractionated heparin). The main plot covers up to 30 days, with separate lines marked for enoxaparin and UFH, showing enoxaparin with a lower hazard rate. A smaller inset graph shows the results at 1 year, with a similar trend. The graph includes a log-rank test p-value indicating statistical significance and a risk table listing patient counts at various time points for both treatments.*

FDA Label Image

Lovenox Premier 10

Instructional diagram showing a Lovenox prefilled syringe injection before and after use. The 'Before Use' side labels the plunger rod, needle, and needle cap. The 'After Use' side labels the plunger rod and protective sleeve covering the needle.*

FDA Label Image

Lovenox Premier 11

An instructional diagram showing the contents of a Lovenox prefilled syringe kit. It includes one Lovenox prefilled syringe, one cotton ball or gauze, one alcohol wipe, one small adhesive bandage, and a sharps disposal container labeled for syringe disposal.*

FDA Label Image

Lovenox Premier 12

An instructional diagram showing hands peeling back the paper packaging from a prefilled syringe, likely illustrating preparation steps for using the Lovenox (enoxaparin sodium) subcutaneous injection.*

FDA Label Image

Lovenox Premier 13

Illustration of a Lovenox (enoxaparin sodium) prefilled injection syringe showing the plunger, barrel with volume markings, and needle cap, with an annotation pointing to the location of the expiration date on the syringe barrel.*

FDA Label Image

Lovenox Premier 14

An illustration of a syringe depicted with clear liquid inside, showing the plunger, barrel, and needle tip components. The label identifies the liquid inside the syringe as clear.*

FDA Label Image

Lovenox Premier 15

An anatomical illustration showing two shaded rectangular areas on the sides of a simplified torso, likely indicating preferred subcutaneous injection sites for medication administration.*

FDA Label Image

Lovenox Premier 16

Illustration showing a hand applying a small adhesive patch or dressing to the lower abdominal area, indicating a step related to subcutaneous injection or site care for Lovenox (enoxaparin sodium) injection administration.*

FDA Label Image

Lovenox Premier 17

Instructional illustration showing two hands preparing an injection syringe. One hand holds a syringe with a visible plunger, and the other hand holds a small cap or cover to be placed or removed from the syringe's needle. Bidirectional arrows indicate the motion of the cap being pulled off or put on the syringe.*

FDA Label Image

Lovenox Premier 18

Illustration showing a hand holding a prefilled syringe with a dose adjustment indicator. The syringe is labeled for setting the dose, with an arrow indicating the downward motion to adjust the dosage. This relates to Lovenox (enoxaparin sodium) injection dosing.*

FDA Label Image

Lovenox Premier 19

An instructional illustration showing a person's hand pinching the skin on the abdomen, likely demonstrating the proper technique for administering a subcutaneous injection such as Lovenox (enoxaparin sodium) injection.*

FDA Label Image

Lovenox Premier 20

Illustration showing the subcutaneous injection technique for Lovenox (enoxaparin sodium) injection. It depicts a hand holding a syringe inserted at a 90-degree angle into the abdominal area, with an arrow indicating the injection direction.*

FDA Label Image

Lovenox Premier 21

An instructional illustration depicting a hand administering a subcutaneous injection to the abdominal area using a syringe. The image shows one hand pinching the skin while the other hand inserts the needle at a slight angle, with an arrow indicating the injection direction.*

FDA Label Image

Lovenox Premier 22

An instructional illustration showing a hand holding a syringe for a subcutaneous injection into the abdominal area, with an arrow indicating the direction of injection. The image is relevant to Lovenox (enoxaparin sodium) injection product usage instructions.*

FDA Label Image

Lovenox Premier 23

Illustration showing a hand holding a syringe for subcutaneous injection. The image features an arrow indicating the direction to move a part of the device until a 'click' is heard, and identifies a 'Protective Sleeve' around the syringe barrel. This likely demonstrates part of the injection or preparation process for Lovenox (enoxaparin sodium) injection.*

FDA Label Image

Lovenox Premier 24

An instructional illustration showing a hand disposing of a Lovenox syringe with needle cap into a Sharps Disposal Container. The syringe and needle cap are labeled, demonstrating safe disposal practices for used injection devices.*

FDA Label Image

Lovenox Premier 25

Packaging label for Lovenox (enoxaparin sodium injection) 30 mg/0.3 mL by Sanofi-Aventis U.S. LLC. The label indicates single dose syringes with automatic safety device intended for subcutaneous injection. The package contains ten 0.3 mL syringes. The label includes storage instructions, dosage form, and safety device activation directions with illustrations.*

FDA Label Image

Lovenox Premier 26

Lovenox 40 mg/0.4 mL (enoxaparin sodium injection) carton label for subcutaneous injection. The packaging holds ten single-dose syringes with automatic safety devices. Label includes detailed administration instructions and storage information. Manufactured by Sanofi-Aventis U.S. LLC, the box highlights the product name, strength, route, and safety features, with a barcode and serialization area visible.*

FDA Label Image

Lovenox Premier 27

Packaging label for Lovenox (enoxaparin sodium injection) 60 mg/0.6 mL, a single-dose syringe with automatic safety device for subcutaneous injection. The carton indicates ten 0.6 mL syringes and is labeled for Rx only. The labeler is Sanofi Aventis U.S. LLC, and instructions for use with illustrations are included on the packaging.*

FDA Label Image

Lovenox Premier 28

Packaging label for Lovenox 80 mg/0.8 mL injection (enoxaparin sodium) by Sanofi-Aventis U.S. LLC. The label details single dose syringes with automatic safety device for subcutaneous injection, includes usage instructions, storage conditions, and warnings. The box contains ten 0.8 mL syringes. The design features orange and white sections with blue text and barcode.*

FDA Label Image

Lovenox Premier 29

Lovenox 100 mg/mL (enoxaparin sodium injection) single dose syringes with automatic safety device for subcutaneous injection. The carton includes ten 1 mL syringes. Labeler is Sanofi-Aventis U.S. LLC. The packaging features instructions for use, warnings, storage information, and barcode.*

FDA Label Image

Lovenox Premier 30

The packaging label for Lovenox 300 mg/3 mL (100 mg/mL) enoxaparin sodium injection. The label indicates this is a human prescription drug for subcutaneous or intravenous injection, supplied as a multiple-dose 3 mL vial. The labeler is Sanofi-Aventis U.S. LLC, with storage and usage directions, warnings, and barcode also visible on the label.*

FDA Label Image

Lovenox Premier 31

Packaging label for Lovenox 120 mg/0.8 mL (enoxaparin sodium injection) by Sanofi-Aventis U.S. LLC. The label states it is a single-dose syringe with an automatic safety device for subcutaneous injection. The box contains ten 0.8 mL syringes. Instructions for use and storage conditions are included on the label, along with the product's barcode and regulatory information.*

FDA Label Image

Lovenox Premier 32

Packaging label for Lovenox (enoxaparin sodium injection) 150 mg/1 mL, a single-dose syringe with an automatic safety device for subcutaneous injection. The label indicates Rx only, a package of ten 1 mL syringes, and is labeled by Sanofi-Aventis U.S. LLC. The label includes dosage information, safety warnings, storage instructions, and usage directions with illustrations.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.